Stock Analysis

November 2024's Leading Growth Companies With Significant Insider Ownership

Published

As global markets navigate the uncertainty surrounding the incoming Trump administration's policies, investors are closely watching sector performances and policy implications for corporate earnings. With U.S. stocks experiencing a partial pullback of recent gains and interest rates showing signs of potential shifts, identifying growth companies with high insider ownership can be particularly appealing in such fluctuating environments. In this context, insider ownership often signals confidence in a company's prospects, making it an important factor to consider when evaluating potential investments amidst current market dynamics.

Top 10 Growth Companies With High Insider Ownership

NameInsider OwnershipEarnings Growth
People & Technology (KOSDAQ:A137400)16.4%37.3%
Archean Chemical Industries (NSEI:ACI)22.9%43%
Kirloskar Pneumatic (BSE:505283)30.3%26.3%
Seojin SystemLtd (KOSDAQ:A178320)31.1%52.4%
On Holding (NYSE:ONON)31%29.7%
Medley (TSE:4480)34%31.5%
Credo Technology Group Holding (NasdaqGS:CRDO)13.8%95%
Plenti Group (ASX:PLT)12.8%107.6%
Brightstar Resources (ASX:BTR)16.2%84.6%
UTI (KOSDAQ:A179900)33.1%134.6%

Click here to see the full list of 1546 stocks from our Fast Growing Companies With High Insider Ownership screener.

Here's a peek at a few of the choices from the screener.

Swedencare (OM:SECARE)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Swedencare AB (publ) develops, manufactures, markets, and sells animal healthcare products for cats, dogs, and horses across Sweden, the United Kingdom, the rest of Europe, North America, Asia, and internationally with a market cap of approximately SEK7.12 billion.

Operations: The company's revenue segments include SEK397.40 million from Europe, SEK659 million from Production, and SEK1.66 billion from North America.

Insider Ownership: 12.2%

Swedencare demonstrates characteristics of a growth company with high insider ownership, evidenced by substantial insider buying in the past three months. Despite a decline in profit margins from 4% to 2.5% year-over-year, earnings are forecast to grow significantly at 64.17% annually over the next three years, outpacing the Swedish market's expected growth. Trading at 68.6% below estimated fair value and with analysts predicting a potential stock price increase of 31%, Swedencare presents an intriguing investment profile.

OM:SECARE Earnings and Revenue Growth as at Nov 2024

JTOWER (TSE:4485)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: JTOWER Inc. offers infrastructure sharing services in Japan with a market capitalization of ¥92.16 billion.

Operations: The company generates revenue from its Telecommunications Infrastructure Sharing Business, amounting to ¥13.15 billion.

Insider Ownership: 18.2%

JTOWER's recent acquisition by DigitalBridge Group, taking it private, indicates a strategic shift in ownership structure. Despite high volatility and past shareholder dilution, JTOWER is expected to achieve profitability within three years with earnings growth forecasted at 63.79% annually. Although revenue growth of 16.1% per year is slower than some benchmarks, it surpasses the broader Japanese market's expectations. The impending delisting from the Tokyo Stock Exchange underscores significant insider involvement and potential restructuring impacts.

TSE:4485 Earnings and Revenue Growth as at Nov 2024

Deutsche Beteiligungs (XTRA:DBAN)

Simply Wall St Growth Rating: ★★★★★☆

Overview: Deutsche Beteiligungs AG is a private equity and venture capital firm specializing in direct and fund of fund investments, with a market cap of €420.63 million.

Operations: The firm's revenue segments include Fund Investment Services at €48.00 million and Private Equity Investments at €27.01 million.

Insider Ownership: 39.6%

Deutsche Beteiligungs is trading significantly below its estimated fair value, with earnings and revenue growth forecasted to outpace the German market substantially—earnings by 54.1% and revenue by 41.7% annually. However, profit margins have decreased markedly from last year, and dividends are not well-covered by earnings or cash flow. Despite low expected return on equity in three years, analysts agree on a potential price increase of 88.2%.

XTRA:DBAN Earnings and Revenue Growth as at Nov 2024

Key Takeaways

Contemplating Other Strategies?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com